Correlation Between Ventyx Biosciences and Travere Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Travere Therapeutics, you can compare the effects of market volatilities on Ventyx Biosciences and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Travere Therapeutics.

Diversification Opportunities for Ventyx Biosciences and Travere Therapeutics

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Ventyx and Travere is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Travere Therapeutics go up and down completely randomly.

Pair Corralation between Ventyx Biosciences and Travere Therapeutics

Given the investment horizon of 90 days Ventyx Biosciences is expected to generate 2.35 times less return on investment than Travere Therapeutics. In addition to that, Ventyx Biosciences is 1.98 times more volatile than Travere Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. Travere Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest  1,810  in Travere Therapeutics on November 2, 2024 and sell it today you would earn a total of  295.00  from holding Travere Therapeutics or generate 16.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ventyx Biosciences  vs.  Travere Therapeutics

 Performance 
       Timeline  
Ventyx Biosciences 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ventyx Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Ventyx Biosciences may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Travere Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Ventyx Biosciences and Travere Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ventyx Biosciences and Travere Therapeutics

The main advantage of trading using opposite Ventyx Biosciences and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.
The idea behind Ventyx Biosciences and Travere Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.